Price-Driven Insight from (CCRN) for Rule-Based Strategy
This article provides a price-driven insight for Cross Country Healthcare Inc. (NASDAQ: CCRN), highlighting strong near-term sentiment potentially challenging persistent mid and long-term weakness. It details an exceptional risk-reward short setup and outlines three distinct institutional trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss zones. The analysis is supported by AI-generated signals and multi-timeframe signal analysis, showing current support and resistance levels.
Citizens reiterates Cross Country Healthcare stock rating ahead of results
Citizens has reiterated a Market Outperform rating for Cross Country Healthcare Inc. (NASDAQ:CCRN) with a price target of $11.00, suggesting a 36% upside. The rating comes ahead of the company's Q4 results and is supported by its strong balance sheet, new CEO, diversified customer base, and capital deployment options. The stock is considered undervalued based on InvestingPro data and is seen as a play on a potential sector recovery.
Citizens reiterates Cross Country Healthcare stock rating ahead of results
Citizens has reaffirmed its Market Outperform rating for Cross Country Healthcare Inc. (NASDAQ:CCRN) with an $11.00 price target, citing the stock's undervaluation, strong balance sheet, and leadership changes. The company, which has no debt and significant cash reserves, is preparing for its fourth-quarter results, with analysts noting its diversified customer base and capital deployment flexibility.
Citizens reiterates Cross Country Healthcare stock rating ahead of results
Citizens has reiterated a Market Outperform rating for Cross Country Healthcare Inc. (NASDAQ:CCRN) with a price target of $11.00, citing the company's strong balance sheet, new CEO, diversified customer base, and capital deployment optionality. The stock appears undervalued according to InvestingPro data, and analysts see it as a play on potential sector recovery. This assessment comes ahead of the company’s fourth-quarter results and recent leadership changes.
Cross Country Healthcare Schedules Q4 and 2025 Earnings Call
Cross Country Healthcare has announced it will hold a conference call on March 4, 2026, to discuss its fourth-quarter and full-year 2025 financial results. The company, a technology-driven healthcare workforce solutions provider, utilizes its AI-enabled Intellify platform to optimize labor costs and clinical outcomes. Current analyst ratings indicate a "Hold" for CCRN stock, with TipRanks' AI Analyst Spark also rating it "Neutral" due to weak financial performance and bearish technical indicators.
Cross Country Healthcare Schedules Q4 and 2025 Earnings Call
Cross Country Healthcare (CCRN), a technology-driven healthcare workforce solutions provider, has announced an earnings call for March 4, 2026, to discuss its fourth-quarter and full-year 2025 financial results. The company utilizes its AI-enabled Intellify platform to help health systems manage staffing and optimize labor costs. Spark, TipRanks’ AI Analyst, has rated CCRN as Neutral due to weak financial performance and bearish technical indicators.
Cross Country Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Wednesday, March 4, 2026
Cross Country Healthcare, Inc. (Nasdaq: CCRN) announced it will host its fourth quarter and full year 2025 earnings conference call on Wednesday, March 4, 2026, at 5:00 P.M. Eastern Time. The company plans to release its financial results after market close on the same day. The call will be webcast live on the company's website and accessible by phone, with replays available afterward.
(CCRN) Price Dynamics and Execution-Aware Positioning
This article analyzes the price dynamics and execution-aware positioning for Cross Country Healthcare Inc. (NASDAQ: CCRN), highlighting near-term weak sentiment which may lead to a resumption of long-term weakness. It details an exceptional risk-reward short setup and provides specific institutional trading strategies across different risk profiles, including long, breakout, and short positions with defined entry points, targets, and stop losses. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
Wedbush Initiates Coverage of Cross Country Healthcare (CCRN) with Neutral Recommendation
Wedbush has initiated coverage on Cross Country Healthcare (CCRN) with a Neutral recommendation. Analysts project a 29.79% upside from the current price, with an average one-year target of $11.68 per share. The company is expected to see a significant 47.41% increase in annual revenue to $1,662 million, and a bullish outlook is indicated by a put/call ratio of 0.47.
CCRN: Wedbush Initiates Coverage with Neutral Rating, Sets $11 PT
Wedbush has initiated coverage on Cross Country Healthcare (CCRN) with a Neutral rating and set a price target of $11.00 USD. This new rating follows other recent analyst actions, including UBS maintaining a Neutral rating but lowering its price target. Investors are advised to consider these ratings and the consensus "Hold" status from eight brokerage firms when making investment decisions for the healthcare staffing company.
CCRN: Wedbush Initiates Coverage with Neutral Rating, Sets $11 P
Wedbush has initiated coverage on Cross Country Healthcare (CCRN) with a Neutral rating and set a price target of $11.00 USD. This new rating follows various analyst actions over the past year, reflecting a cautious outlook on the healthcare staffing company's stock performance. Based on analyst forecasts, the average target price for CCRN is $9.66, implying an 8.81% upside from the current price, with a consensus brokerage recommendation of "Hold."
Cross Country Sets Earlier Virtual 2026 Annual Meeting
Cross Country Healthcare (CCRN) has moved its 2026 Annual Meeting of Stockholders to May 11, 2026, making it a virtual-only event and adjusting key deadlines for stockholder proposals. TipRanks' AI Analyst, Spark, rates CCRN as Neutral due to weak financial performance, bearish technical indicators, and a negative P/E ratio, despite positive leadership changes. The company provides staffing and workforce solutions in the healthcare sector, with a current market cap of $302M.
Cross Country Healthcare sets date for 2026 annual meeting and proposal deadlines
Cross Country Healthcare (NASDAQ: CCRN) has announced its 2026 Annual Meeting of Stockholders will be held virtually on May 11, 2026. Due to the meeting being advanced by over 30 days, new deadlines for stockholder proposals and director nominations have been set, with March 11, 2026, for proxy statement inclusions and February 10, 2026, for other business proposals. The company also recently appointed co-founder Kevin C. Clark as the new President and CEO.
Cross Country Healthcare sets date for 2026 annual meeting and proposal deadlines
Cross Country Healthcare, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on May 11, 2026. Due to the advanced meeting date, revised deadlines for stockholder proposals and nominations have been set for March 11, 2026, and February 10, 2026, respectively. The company also recently appointed Kevin C. Clark as President and CEO, following the departure of John A. Martins.
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
Cross Country Healthcare (CCRN) reported Q1 earnings of $0.06 per share, surpassing the Zacks Consensus Estimate of $0.04. Despite beating earnings expectations, the company missed revenue estimates by 3.67%, with revenues of $293.41 million. The stock currently holds a Zacks Rank #4 (Sell), indicating a potential underperformance in the near future.
Cross Country Healthcare (NASDAQ:CCRN) Raised to Hold at Zacks Research
Zacks Research upgraded Cross Country Healthcare (NASDAQ:CCRN) from a "strong sell" to a "hold" rating. The company recently missed its quarterly earnings and revenue expectations,
Cross Country Healthcare partners with Burnalong to enhance employee wellness
Cross Country Healthcare has announced a partnership with Burnalong, an online wellness platform, to provide comprehensive wellness resources to its benefit-eligible employees. This collaboration aims to improve various aspects of employee well-being, including fitness, mindfulness, nutrition, sleep, and financial wellness. The initiative highlights the company's commitment to fostering a supportive workplace culture and promoting long-term organizational success.
(CCRN) Risk Channels and Responsive Allocation
This article provides an in-depth analysis of Cross Country Healthcare Inc. (NASDAQ: CCRN), highlighting strong near and mid-term sentiment but a weak long-term outlook. It identifies a mid-channel oscillation pattern and an exceptional short setup targeting 20.0% downside with minimal risk. The analysis also details three institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—alongside multi-timeframe signal analysis and AI-generated signals.
Cross Country Healthcare signals gratitude and future success
Cross Country Healthcare has expressed profound gratitude towards its professionals, partners, and clients, acknowledging their role in the company's achievements. Despite an original tweet being deleted, the content conveyed the company's appreciation and its optimistic outlook for the upcoming year. The details regarding future plans are currently being clarified.
Cross Country Healthcare Personnel Placement Service Market
Worldwide Market Reports has published a new research study on the Cross Country Healthcare Personnel Placement Service Market, predicting substantial growth in the coming years. The report provides a comprehensive analysis of the market landscape, including dynamics, drivers, restraints, and growth opportunities, covering various segments like Travel Nursing and Temporary Staffing. It also offers regional insights, competitive analysis of key players like AMN Healthcare and Cross Country Healthcare, and details on research methodology.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Receives Average Recommendation of "Hold" from Brokerages
Cross Country Healthcare, Inc. (NASDAQ:CCRN) has an average "Hold" recommendation from eight brokerage firms, with an average 12-month price target of $11.38. The company recently missed Q3 earnings and revenue estimates, reporting EPS of $0.03 against an expected $0.04 and revenue of $250.05M versus $270.72M. Institutional investors hold approximately 96% of the stock, with several hedge funds increasing their positions recently.
Citizens maintains Cross Country Healthcare stock rating, cites discount to peer
Citizens has reiterated its Market Outperform rating on Cross Country Healthcare (NASDAQ:CCRN) with a price target of $11.00, aligning closely with InvestingPro’s Fair Value assessment, which suggests the stock is currently undervalued at $8.03. The firm noted CCRN is trading at a significant discount to its peer AMN Healthcare based on 2026 EBITDA estimates. This news follows a leadership change at CCRN, with Kevin C. Clark appointed new President and CEO, and shareholders approving all agenda items at the annual meeting.
Caxton Associates LLP Makes New Investment in Cross Country Healthcare, Inc. $CCRN
Caxton Associates LLP has made a new investment in Cross Country Healthcare (NASDAQ:CCRN), acquiring 205,143 shares valued at approximately $2.68 million in Q2, representing 0.63% ownership. Other institutional investors like Moore Capital and LMR Partners also increased their stakes, bringing total institutional ownership to 96.03%. Analysts have mixed ratings, with a consensus "Hold" and a target price of $11.65, after the company missed recent revenue and EPS estimates.
Cross Country Healthcare stock rating maintained by Citizens analyst
Citizens analyst reiterated a Market Outperform rating and $11.00 price target on Cross Country Healthcare (NASDAQ:CCRN), maintaining the rating based on an 8x 2026 EBITDA valuation. The firm noted CCRN recently traded at 6.4x NTM EBITDA and sees a more normalized trading range for the company between 8x-11x forward EBITDA. Citizens also expressed a positive outlook on the new CEO Mr. Clark and the company's strengthened financial position with no debt.
Cross Country CEO exits as founder returns
Cross Country Healthcare announced the departure of CEO John A. Martins and the return of co-founder Kevin C. Clark as President and CEO. This leadership change follows the recently canceled sale of Cross Country to Aya Healthcare. Clark, who previously led the company, will also continue in his role as board chairman, aiming to drive growth through AI-led, tech-enabled workforce solutions.
Cross Country Healthcare names co-founder Kevin Clark as new CEO
Cross Country Healthcare (NASDAQ: CCRN) has appointed co-founder Kevin C. Clark as President and CEO, effective December 14, 2025. This leadership change occurs as the company faces profitability challenges and follows the termination of a proposed merger with Aya Healthcare. Clark, who previously led the company during a period of significant growth, aims to reduce costs and optimize capital allocation for long-term profitable growth.
Cross Country Healthcare (Nasdaq: CCRN) taps Kevin Clark as CEO amid transition
Cross Country Healthcare has appointed co-founder and former CEO Kevin C. Clark as its new President and CEO, effective December 14, 2025, following the departure of John A. Martins. Martins will receive significant severance, including two years of his base salary of $875,000 and full vesting of equity awards, while Clark's compensation terms are yet to be finalized. This leadership change also saw a reduction in the board size from seven to six members.
Cross Country Healthcare stock rises after CEO change
Cross Country Healthcare Inc (NASDAQ:CCRN) stock rose in premarket trading after the company announced a leadership change, appointing Chairman and Co-Founder Kevin C. Clark as its new President and CEO. Clark replaces John A. Martins, who has separated from the company. This transition occurred after the termination of a previously announced transaction with Aya Healthcare, leading the Board to determine it was "the right time for a CEO transition."
Cross Country Healthcare names co-founder Kevin Clark as new CEO
Cross Country Healthcare (NASDAQ:CCRN) has announced the appointment of co-founder Kevin C. Clark as President and CEO, effective December 14, 2025. This leadership change occurs as the company grapples with a stock decline of over 53% year-to-date and follows the termination of a proposed merger with Aya Healthcare. Clark, who previously led the company from 2019 to 2022, aims to focus on cost reduction and capital allocation for profitable growth, despite the company not being profitable over the last twelve months.
Cross Country Healthcare shareholders approve board slate and auditor at annual meeting
Cross Country Healthcare, Inc. (NASDAQ:CCRN) shareholders approved the election of seven directors for one-year terms, ratified Deloitte & Touche as the independent public accounting firm for fiscal year 2025, and provided advisory approval for named executive officers' compensation at their annual meeting. These approvals follow a period of operational challenges for the company, including a terminated merger with Aya Holdings and lower-than-anticipated Q3 earnings.
Cross Country Healthcare shareholders approve board slate and auditor at annual meeting
Cross Country Healthcare (NASDAQ: CCRN) shareholders approved all agenda items at their annual meeting, including the election of seven directors for one-year terms and the ratification of Deloitte & Touche as their accounting firm for 2025. Additionally, stockholders provided advisory approval for the compensation of named executive officers. These approvals come amidst recent challenges for the company, including disappointing third-quarter results and the termination of a proposed merger with Aya Holdings due to FTC concerns.
Cross Country Healthcare: Failed Merger Disappointing, But Selling Here Would Be A Mistake
Cross Country Healthcare's merger with Aya Healthcare collapsed due to unforeseen circumstances, including a government shutdown and the death of Aya's CEO, leading CCRN to receive a $20 million termination fee. Despite the disappointment, the company plans up to $40 million in share buybacks, capitalizing on a lower stock price. With its fundamentals intact and trading below pre-merger levels, the article maintains a Buy rating for CCRN based on its valuation and potential for upside.
Aya Healthcare terminates merger agreement with Cross Country Healthcare
Aya Healthcare has terminated its merger agreement to acquire Cross Country Healthcare, citing shifting market conditions, extensive time and resources for regulatory clearance, and unmet closing deadlines due to a US government shutdown. Although both companies believed in the transaction's merits, Aya Healthcare will pay a $20 million termination fee to Cross Country Healthcare, which plans to immediately commence stock repurchases. Cross Country Healthcare maintains a strong independent position and is focused on its strategic plan for accelerated growth.
UBS Maintains Cross Country Healthcare (CCRN) Neutral Recommendation
UBS has reiterated its Neutral recommendation for Cross Country Healthcare (CCRN) as of December 9, 2025. Fintel reports that the average one-year price target for CCRN is $14.97, suggesting an 83.88% upside from its current price of $8.14. Institutional ownership remains strong, with key holders like Magnetar Financial and Alliancebernstein making significant moves in the last quarter.
Cross Country Healthcare stock falls as Aya merger terminated on FTC concerns
Cross Country Healthcare (NASDAQ:CCRN) and Aya Holdings have terminated their proposed merger after one year, with Aya citing uncertainty and potential challenges from the Federal Trade Commission (FTC), which had identified competitive concerns. Cross Country Healthcare's stock fell, and it will receive a $20 million breakup fee. The company plans to repurchase shares under an existing authorization.
Aya Healthcare, Cross Country terminate staffing acquisition following FTC scrutiny
Aya Healthcare has abandoned its $615 million acquisition of Cross Country Healthcare after extensive antitrust review by the Federal Trade Commission (FTC). The FTC expressed significant competitive concerns, arguing the merger would eliminate competition between two major healthcare staffing software providers. A 43-day government shutdown impacted the review timeline, pushing it past the deal's termination date.
Aya Healthcare, Cross Country terminate staffing acquisition following FTC scrutiny
Aya Healthcare and Cross Country Healthcare have terminated their $615 million staffing acquisition due to prolonged Federal Trade Commission (FTC) scrutiny. The FTC raised "significant competitive concerns," stating the deal would eliminate competition between two major healthcare staffing software providers. A government shutdown extended the antitrust review past the deal's termination date, leading to its collapse, and Aya will pay Cross Country a $20 million termination fee.
Skandinaviska Enskilda Banken AB publ Increases Stake in Cross Country Healthcare, Inc. $CCRN
Skandinaviska Enskilda Banken AB publ significantly increased its stake in Cross Country Healthcare, Inc. by 175% in the second quarter, bringing its total ownership to 0.50% of the company. Despite this, Cross Country Healthcare recently missed Q2 earnings and revenue expectations, and carries an average analyst rating of "Reduce" with its stock trading near a 52-week low. Institutional investors now collectively own about 96.03% of the company's stock.
Cross Country Healthcare Ends Merger with Aya Holdings
Cross Country Healthcare (CCRN) has terminated its merger agreement with Aya Holdings II Inc. due to the failure to meet the consummation deadline, partly caused by an extended FTC review. As a result, Aya Healthcare will pay a $20 million termination fee to Cross Country Healthcare, which plans to proceed with share repurchases. Analysts currently rate CCRN as a Hold due to financial performance challenges and a bearish technical outlook.
Aya Healthcare, Cross Country terminate deal
Aya Healthcare and Cross Country Healthcare have terminated their merger agreement, leading to Aya Healthcare paying a $20 million termination fee to Cross Country. The deal's termination was announced via an official statement. This news was reported by MLex, an organization specializing in legal risk and regulation.
Cross Country Healthcare Terminates Merger Agreement With Aya Healthcare
Cross Country Healthcare (NASDAQ: CCRN) has terminated its merger agreement with Aya Healthcare due to an extended HSR waiting period caused by a government shutdown. Despite efforts to shorten the review period, Cross Country Healthcare was unable to reach an agreement with Aya Healthcare to extend the merger beyond December 3, 2025. Cross Country Healthcare will receive a $20 million termination fee and plans to immediately commence share repurchases under its existing $40 million authorization.
Aya Healthcare Terminates Proposed Acquisition of Cross Country Healthcare
Aya Healthcare has terminated its proposed acquisition of Cross Country Healthcare due to shifting market conditions, extensive invested resources, and the anticipated prolonged uncertainty from regulatory clearance. Both companies acknowledge the merits of the transaction but decided not to proceed, allowing Aya to focus on its long-term strategic priorities of innovation and technology platform strengthening. Emily Hazen, CEO of Aya Healthcare, expressed pride in the collaboration and confidence in Aya's ability to lead the industry.
Analysis: Aya’s canceled Cross Country merger to ripple through healthcare staffing
The termination of Aya Healthcare's acquisition of Cross Country Healthcare, originally announced in December 2024, will have widespread implications across the healthcare staffing industry. Clinicians, health systems, and small to midsize competitors will see different effects, with the decision preserving competition and offering more options for clinicians while allowing both Aya and Cross Country to pursue independent growth strategies. The decision maintains market dynamics where competition among firms remains a key factor.
Cross Country Healthcare Merger Agreement with Aya Healthcare Terminated
Cross Country Healthcare (CCRN) announced the termination of its merger agreement with Aya Healthcare after failing to agree on an extension beyond December 3, 2025, due to a prolonged FTC review stemming from a government shutdown. Aya Healthcare will pay a $20 million termination fee, and Cross Country Healthcare plans to immediately commence share repurchases under its existing $40 million authorization. Despite the termination, CEO John A. Martins expressed confidence in the company's strategic plan and future growth.
Cross Country Healthcare Merger Agreement with Aya Healthcare Terminated
Cross Country Healthcare (CCRN) announced the termination of its merger agreement with Aya Healthcare due to an extended HSR waiting period that surpassed the merger agreement's termination date, exacerbated by a government shutdown. Aya Healthcare will pay a $20 million termination fee. Cross Country Healthcare plans to immediately commence share repurchases under its existing $40 million authorization and remains committed to its strategic plan for growth.
CROSS COUNTRY HEALTHCARE INC SEC 10-Q Report
Cross Country Healthcare Inc. (CCRN) released its Q3 2025 Form 10-Q report, detailing a significant decrease in revenue and net loss primarily due to volume declines in its Nurse and Allied Staffing and Physician Staffing segments. Despite these challenges, the company saw growth in Homecare Staffing and is moving forward with a merger with Aya Healthcare, which will make it a private entity. The report also highlights operational challenges including macroeconomic factors, inflationary pressures, and uncertain demand.
Research Analysts Set Expectations for CCRN FY2026 Earnings
Research analysts at William Blair have significantly cut their FY2026 earnings per share forecast for Cross Country Healthcare (CCRN) to $0.05 from $0.16, with a consensus current full-year estimate of $0.53. This revision follows Cross Country Healthcare missing its most recent quarterly earnings and revenue estimates. The stock currently holds an average "Reduce" rating from analysts with a target price of $17.91, while trading around $11.13.
Cross Country Healthcare’s Financial Stability at Risk: Unforeseen Challenges Ahead
Cross Country Healthcare (CCRN) has disclosed new risks that could impact its financial stability and operations, beyond those detailed in its 2024 Form 10-K. The company acknowledges potential unforeseen challenges, urging stakeholders to remain vigilant. Wall Street currently holds a "Hold" consensus rating on CCRN stock.
Cross Country Healthcare (CCRN) Lags Q3 Earnings and Revenue Estimates
Cross Country Healthcare (CCRN) reported disappointing Q3 earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 and significantly down from $0.12 a year ago. The company also failed to meet revenue expectations, posting $250.05 million against an estimated $267.36 million. Due to these results and an unfavorable earnings outlook, the stock currently holds a Zacks Rank #4 (Sell).
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Given Consensus Recommendation of "Reduce" by Brokerages
Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received a consensus "Reduce" recommendation from seven brokerages, with an average 12-month price target of approximately $17.91. The company recently missed earnings and revenue estimates, reporting ($0.01) EPS versus $0.07 expected and $274.1M revenue versus $292.7M. Despite institutional ownership of 96.03%, the stock traded down 5.1% after the earnings release, with a market cap of around $405M and a negative P/E.
